Return to FDA: Senate Staffer Dorsey Takes Senior Counselor Position To Sharfstein
This article was originally published in The Pink Sheet Daily
Executive Summary
Kennedy health staffer will serve as part of senior leadership team.
You may also be interested in...
FDA Associate Commissioners Transition As PDUFA IV Rolls Over To V
Peter Lurie will replace David Dorsey as Acting Associate Commissioner for Policy and Planning, and Melinda Plaisier becomes Acting Associate Commissioner for Regulatory Affairs as Dara Corrigan moves to FDA’s European office.
FDA Acting Chief Counsel Choice Landa Underscores Administration Priorities
Michael Landa brings knowledge of foods, devices to position as FDA's top lawyer.
US Medicare Plans 'Can' Cover Wegovy, CMS Says, But Will They?
Medicare is making clear that Part D ‘can’ cover GLP-1 inhibitors that are approved for cardiovascular indications – but in language that seems to leave plans considerable discretion for now. The formulary review process for 2025 may be a more important milestone for changes.